Filtros de búsqueda

Lista de obras de

A Mildly Symptomatic Middle-Aged Woman with INT-1 Primary Myelofibrosis

scientific article published on 01 September 2020

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients

artículo científico publicado en 2020

A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center.

artículo científico publicado en 2017

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

artículo científico publicado en 2020

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

artículo científico publicado en 2011

A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results

artículo científico publicado en 2017

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

artículo científico publicado en 2013

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas

artículo científico

Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation

artículo científico publicado en 2018

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

artículo científico publicado en 2013

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

artículo científico publicado en 2000

Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation

artículo científico publicado en 2015

Age is a prognostic factor for the overall survival of multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation

artículo científico publicado en 2019

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

artículo científico publicado en 2017

Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial

artículo científico publicado en 2019

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

artículo científico publicado en 2017

Allogeneic Hematopoietic Stem-Cell Transplantation in Myelofibrosis: Key Messages for Clinical Practice in the Era of Janus Kinase 1/2 Inhibitors.

artículo científico publicado en 2016

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2018

Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results

artículo científico publicado en 2019

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age ⬇️

artículo científico publicado el 17 de febrero de 2011

Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes

artículo científico

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

artículo científico publicado en 2007

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

artículo científico publicado en 2013

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

artículo científico publicado en 2005

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

artículo científico publicado en 2014

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

artículo científico publicado en 2010

Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution

artículo científico publicado en 2015

Allotransplants for patients 65 years or older with high-risk acute myeloid leukemia

article

An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors

artículo científico

Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial

artículo científico publicado en 2008

Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation

artículo científico publicado en 2011

Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia

artículo científico publicado en 2017

Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up

artículo científico publicado en 2014

Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients

artículo científico publicado en 2015

Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial

artículo científico publicado en 2016

Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement

artículo científico publicado en 2015

Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

artículo científico publicado en 2009

Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.

artículo científico publicado en 2012

Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma

scientific article published on 29 January 2007

Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

scientific article published on 02 October 2020

BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

artículo científico publicado en 2014

Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

artículo científico publicado en 2016

Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

artículo científico publicado en 2015

Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM

scientific article published on 01 October 2020

Bystander Transfer of Functional Human CD40 Ligand from Gene-Modified Fibroblasts to B-Chronic Lymphocytic Leukemia Cells ⬇️

artículo científico publicado el 10 de abril de 2003

CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors

artículo científico publicado en 2005

Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?

artículo científico publicado en 2014

Can we cure refractory Hodgkin's lymphoma with transplantation?

artículo científico publicado en 2020

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis

artículo científico publicado en 2004

Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis

artículo científico publicado en 2014

Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

artículo científico publicado en 2016

Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2012

Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.

scientific article published on 11 October 2010

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens

scientific article published on 11 January 2019

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS

artículo científico publicado en 2020

Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease

artículo científico publicado en 2015

Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators

artículo científico publicado en 2015

Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2015

Concise review: umbilical cord blood transplantation: past, present, and future

artículo científico publicado en 2014

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial

scientific article published on 22 March 2019

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

artículo científico publicado en 2016

Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases

artículo científico publicado en 2005

Cord-blood engraftment with ex vivo mesenchymal-cell coculture

artículo científico publicado en 2012

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis

scientific article published on 03 April 2019

Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission

artículo científico publicado en 2013

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

artículo científico publicado en 2020

Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning

artículo científico publicado en 2017

Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation.

artículo científico publicado en 2014

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab

artículo científico publicado en 2005

Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hemaptopoietic Stem Cell Transplantation

artículo científico publicado en 2022

Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant

scientific article published on 16 July 2007

Development and validation of a risk assessment tool for BKPyV Replication in Allogeneic Stem cell Transplant Recipients

scientific article published on 30 June 2020

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.

artículo científico publicado en 2008

Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation

Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease.

artículo científico publicado en 2014

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center

artículo científico publicado en 2012

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

artículo científico publicado en 2017

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

artículo científico publicado en 2009

Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.

scientific article published on 20 May 2016

Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma.

artículo científico publicado en 2015

Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant

artículo científico publicado en 2012

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia

artículo científico publicado en 2018

Effect of non-permissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T cell depletion

artículo científico publicado en 2018

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

artículo científico publicado en 2015

Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells

artículo científico publicado en 2018

Every case of essential thrombocythemia should be tested for the Philadelphia chromosome

artículo científico publicado en 2005

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

artículo científico publicado en 2017

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

artículo científico publicado en 2006

Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients

artículo científico publicado en 2020

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

artículo científico publicado en 2017

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma

artículo científico publicado en 2011

Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma

scientific article published on 01 June 2006

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial

artículo científico publicado en 2018

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

artículo científico publicado en 2016

Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia ⬇️

artículo científico publicado el 12 de octubre de 2010

Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

artículo científico publicado en 2016

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results

artículo científico publicado en 2011

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase

artículo científico publicado en 2020

Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes

artículo científico publicado en 2020

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant

scientific article published on 23 January 2019

HLA-mismatched bone marrow transplantation in severe aplastic anemia

artículo científico publicado en 2017

Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia

artículo científico publicado en 2003

Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

artículo científico publicado en 2017

Haploidentical Transplants for Patients with Graft Failure After the First Allograft

scientific article published on 29 June 2020

Haploidentical Transplants for Patients with Relapse After the First Allograft

artículo científico publicado en 2020

Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation

artículo científico publicado en 2019

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups

artículo científico publicado en 2015

Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment

artículo científico publicado en 2015

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

artículo científico publicado en 2008

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis

artículo científico publicado en 2014

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

artículo científico publicado en 2010

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.

artículo científico publicado en 2015

High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation

artículo científico publicado en 2011

High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension.

artículo científico publicado en 2006

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

artículo científico publicado en 2008

High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma

artículo científico publicado en 2013

High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome

artículo científico publicado en 1998

High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan

artículo científico publicado en 2017

High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies

artículo científico publicado en 2012

High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes

scientific article published on 22 July 2018

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease

artículo científico publicado en 2017

IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

artículo científico publicado en 2016

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial

artículo científico publicado en 2016

Idiopathic myelofibrosis without dacryocytes.

artículo científico publicado en 2006

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

scientific article published on 01 April 2020

Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial

artículo científico publicado en 2015

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

artículo científico publicado en 2005

Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis

artículo científico publicado en 2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma

scientific article published on 11 February 2019

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes

artículo científico publicado en 2017

Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

artículo científico publicado en 2017

Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2018

Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 16 September 2020

Impact of TKI maintenance post-allogeneic transplant in Philadelphia positive acute lymphoblastic leukemia

artículo científico publicado en 2020

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

artículo científico publicado en 2018

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.

artículo científico publicado en 2013

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation

artículo científico publicado en 2020

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

artículo científico publicado en 2009

Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.

artículo científico publicado en 2013

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma

artículo científico publicado en 2009

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

artículo científico publicado en 2012

Improving Survival After Transplant in Myelofibrosis

scientific article published on 01 September 2020

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation

artículo científico publicado en 2013

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

artículo científico publicado en 2017

Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL

artículo científico publicado en 2012

Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.

artículo científico publicado en 2010

Is a matched unrelated donor search needed for all allogeneic transplant candidates?

Is there an expiration date for a cord blood unit in storage?

artículo científico publicado en 2014

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

scientific article published on 01 February 2020

Janus Kinase Inhibitors and Stem Cell Transplantation in Myelofibrosis

artículo científico

Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.

artículo científico publicado en 2013

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation

artículo científico publicado en 2015

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

artículo científico publicado en 2016

Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome

artículo científico publicado en 2018

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes

artículo científico publicado en 2011

Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival

artículo científico publicado en 2017

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

artículo científico publicado en 2011

Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

artículo científico publicado en 2020

Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage

artículo científico publicado en 2014

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

scientific article published on 25 October 2019

Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index

artículo científico publicado en 2017

Marrow fibrosis does not account for circulating CD34+ cells in myelofibrosis with myeloid metaplasia

scientific article published on 01 April 2007

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

artículo científico publicado en 2009

Melphalan based autologous transplant in octogenarian multiple myeloma patients

article

Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

artículo científico publicado en 2015

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation

scientific article published on 11 July 2019

Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2009

Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes

artículo científico publicado en 2004

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

artículo científico publicado en 2019

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

article

New onset of myelofibrosis in association with pulmonary arterial hypertension

scientific article published on 01 September 2005

Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

artículo científico publicado en 2009

Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

artículo científico publicado en 2012

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation

scientific article published on 10 September 2019

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis

artículo científico publicado en 2019

Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2015

Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2015

Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2016

Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction

artículo científico publicado en 2009

Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.

artículo científico publicado en 2017

Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement

artículo científico publicado en 2016

Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)

scientific article published on 01 March 2006

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

artículo científico publicado en 2015

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes

artículo científico publicado en 2017

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

artículo científico publicado en 2016

Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant ⬇️

artículo científico publicado en 2016

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis

artículo científico publicado en 2016

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.

artículo científico publicado en 2015

Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci ⬇️

artículo científico publicado el 20 de octubre de 2010

Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2013

Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years

artículo científico publicado en 2019

Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia

scientific article published on 26 June 2019

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

artículo científico publicado en 2012

Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma

artículo científico publicado en 2017

Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.

artículo científico publicado en 2017

Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers

artículo científico publicado en 2013

Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma

scientific article published on 26 April 2011

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

artículo científico publicado en 2016

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

artículo científico publicado en 2015

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

artículo científico publicado en 2015

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma

artículo científico publicado en 2018

Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma

artículo científico publicado en 2010

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

scientific article published on 18 October 2018

Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.

artículo científico publicado en 2011

Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma

artículo científico publicado en 2009

Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients

artículo científico publicado en 2016

Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

artículo científico publicado en 2016

Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors

scientific article published on 03 March 2020

Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia

artículo científico publicado en 2016

Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.

artículo científico publicado en 2017

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.

artículo científico publicado en 2016

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

artículo científico publicado en 2012

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

scientific article published on 28 June 2019

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

artículo científico publicado en 2004

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

scientific article published on 16 May 2018

Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

artículo científico publicado en 2020

Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma

artículo científico publicado en 2016

Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study

artículo científico publicado en 2010

Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia

artículo científico publicado en 2016

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML

scientific article published on 01 March 2020

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant

artículo científico publicado en 2011

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

artículo científico publicado en 2020

Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS

artículo científico publicado en 2018

Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma

artículo científico publicado en 2010

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

artículo científico publicado en 2013

Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation

artículo científico publicado en 2017

Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 06 January 2010

Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia

artículo científico publicado en 2005

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

artículo científico publicado en 2016

Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

artículo científico publicado en 2010

Risk factors for falls in older patients with cancer.

artículo científico publicado en 2017

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma

article

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

artículo científico

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation

artículo científico publicado en 2013

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

artículo científico publicado en 2016

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning

artículo científico publicado en 2014

Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation

artículo científico publicado en 2017

Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma

artículo científico publicado en 2014

Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

artículo científico publicado en 2020

Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission

artículo científico publicado en 2012

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

artículo científico publicado en 2014

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

artículo científico publicado en 2016

Successful treatment of aplastic anemia-paroxysmal nocturnal hemoglobinuria associated with eosinophilic fasciitis with matched unrelated donor allogeneic peripheral blood stem cell transplantation.

artículo científico publicado en 2016

Survival following allogeneic transplant in patients with myelofibrosis

artículo científico publicado en 2020

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients

artículo científico publicado en 2015

Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation

artículo científico

The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes

artículo científico publicado en 2009

The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era

artículo científico publicado en 2020

The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis

scientific article published on 07 October 2004

The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation

artículo científico publicado en 2013

The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms

artículo científico publicado en 2008

The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes

artículo científico publicado en 2010

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes

artículo científico publicado en 2016

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

article by Joshua N Kellner et al published 2 November 2018 in Oncotarget

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

scientific article published on 14 July 2020

Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia

artículo científico publicado en 2004

Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment

artículo científico publicado en 2007

Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation

artículo científico publicado en 2020

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

scientific article published on 05 July 2007

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

artículo científico publicado en 2004

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia

artículo científico publicado en 2015

Umbilical cord blood graft engineering: challenges and opportunities.

artículo científico

Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission ⬇️

artículo científico publicado el 16 de noviembre de 2010

Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation

artículo científico publicado en 2022

Vitamin D receptor upregulation in alloreactive human T cells

artículo científico publicado en 2012

Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda